Unexplained chest/epigastric pain is a common symptom in the general population. However, it has not previously been studied whether such pain could be a marker of subsequent gastrointestinal cancer. We aimed to estimate the risk of gastrointestinal cancers in a Danish 10-year follow-up study among patients with chest/epigastric pain, normal upper endoscopy, and no prior discharge diagnosis of ischemic heart disease (N = 386), compared with population controls (N = 3860). The overall 10-year risk of gastrointestinal cancer (stomach, colorectal, liver, and pancreas) was 2.9% for patients with unexplained chest/epigastric pain vs. 1.5% for controls. The adjusted relative risks <1 year and > or =1 year after upper endoscopy were 8.4 (95% confidence interval [CI], 2.6-27.5) and 1.2 (95% CI, 0.5-2.9), respectively. We found that patients with unexplained chest/epigastric pain have an increased risk of gastrointestinal cancer within the first year after upper endoscopy. Consequently, unexplained chest/epigastric pain might be an early gastrointestinal cancer symptom.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10620-007-9812-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Takotsubo syndrome during treatment with 5-fluorouracil.
Tidsskr Nor Laegeforen
December 2023
Avdeling for blod- og kreftsykdommer, Stavanger universitetssykehus.
Background: Fluoropyrimidines have been linked to cardiovascular toxicity.
Case Presentation: A woman in her forties with locally advanced rectal cancer received curative-intent treatment according to the RAPIDO protocol. Shortly after starting the first 5-fluorouracil infusion she developed chest/epigastric pain, nausea and vomiting.
G-CSF and G-CSF-related vasculitis: a systematic review of the literature and intriguing future research perspectives.
Future Oncol
November 2021
Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, Italy.
There are several case reports suggesting that G-CSFs may, in rare conditions, produce serious side effects, such as vasculitis. A systematic search was conducted in Medline via PubMed, Embase and Cochrane Library to describe this unusual side effect to raise awareness among clinicians for early recognition and treatment. Fifty-seven patients were analyzed.
View Article and Find Full Text PDFMinimally invasive surgical management of Boerhaave's syndrome: a narrative literature review.
J Thorac Dis
August 2020
Department of Biomedical Science for Health, Division of General Surgery, University of Milan, Istituto Clinico Sant'Ambrogio, Milan, Italy.
Treatment of Boerhaave's syndrome is controversial. Formal thoracotomy and laparotomy were considered the gold standard treatment in the past. However, these approaches are associated with significant surgical trauma, stress, and postoperative pain.
View Article and Find Full Text PDFThe threatened stomach: management of the acute gastric volvulus.
Surg Endosc
May 2016
Northern Oesophago-Gastric Unit, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, England, UK.
Introduction: Acute presentation of gastric volvulus is a rare condition with a high mortality for acute ischaemia. This study was undertaken to investigate the acute management, diagnosis, and long-term outcomes of patients presenting with acute gastric volvulus.
Methods: Cases were reviewed retrospectively from 2004 to 2014.
Unexplained chest/epigastric pain in patients with normal endoscopy as a predictor for ischemic heart disease and mortality: a Danish 10-year cohort study.
BMC Gastroenterol
July 2008
Department of Clinical Epidemiology, Aarhus and Aalborg Hospital, Aarhus, University Hospital, DK-8000 Aarhus C, Denmark.
Background: Normal upper endoscopy may be a marker of ischemic heart disease in patients with unexplained chest/epigastric pain.
Methods: We examined the 10-year risk of ischemic heart disease and mortality in a cohort of 386 Danish patients with chest/epigastric pain, normal upper endoscopy, and no prior hospital discharge diagnosis of ischemic heart disease (defined as patients with unexplained chest/epigastric pain), compared with 3,793 population controls matched by age, gender, and residence. Outcome data were obtained from population-based health registries.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!